Transcriptomic Profiling and Drug Repurposing Identify Fostamatinib as a Candidate Therapeutic Agent for IgG4-Related Sialadenitis

Modern Rheumatology · Published 2026-07-10 · DOI 10.1093/mr/roag059

Authors (5)

Motohisa Yamamoto, Ryuta Kamekura, Masaaki Uehara, Yuta Ichii, Kenichi Takano

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yamamoto, M., Kamekura, R., Uehara, M., et al. (2026). Transcriptomic Profiling and Drug Repurposing Identify Fostamatinib as a Candidate Therapeutic Agent for IgG4-Related Sialadenitis. Modern Rheumatology. https://doi.org/10.1093/mr/roag059

Related articles

• Clinical performance of three anti-dsDNA antibody immunoassays in systemic lupus erythematosus · Modern Rheumatology · 2026 · Same journal
• Autoantibodies against adenosine deaminase acting on RNA1 in patients with systemic lupus erythematosus: Its relationship to clinical features and other autoantibodies · Modern Rheumatology · 2026 · Same journal
• Treatment outcomes of periprosthetic fracture following unlinked total elbow arthroplasty: A case series study · Modern Rheumatology · 2026 · Same journal
• Efficacy and safety of canakinumab in patients with adult-onset Still’s disease: Results from an open-label phase III study in Japan · Modern Rheumatology · 2026 · Same journal
• Disentangling temporal factors in organ damage accrual in systemic lupus erythematosus: Onset-age, onset-era, and ageing in the Japanese LUNA registry · Modern Rheumatology · 2026 · Same journal
• Inebilizumab treatment in Japanese patients with IgG4-related disease: A subgroup analysis of a randomized, double-blind, placebo-controlled, phase 3 trial (MITIGATE) · Modern Rheumatology · 2026 · Same journal
• Prevalence of and factors associated with radiographic sacroiliitis in Japanese patients with inflammatory bowel disease: A computed tomography–based study · Modern Rheumatology · 2026 · Same journal
• Effectiveness and safety of sarilumab in polymyalgia rheumatica: A retrospective study of the FIRST registry · Modern Rheumatology · 2026 · Same journal
• Impact of anti-drug antibodies and neutralising antibodies on safety and efficacy of ozoralizumab in rheumatoid arthritis · Modern Rheumatology · 2026 · Same journal
• Assessment of residual symptoms using the Okomarigoto Sheet can complement evaluation of the patient acceptable symptom state in patients with rheumatoid arthritis · Modern Rheumatology · 2026 · Same journal